Item Type | Name |
Concept
|
Adolescent
|
Concept
|
Homeless Youth
|
Concept
|
Leukemia, Myeloid, Acute
|
Concept
|
Leukemia, Myelomonocytic, Chronic
|
Concept
|
Adolescent Development
|
Concept
|
Young Adult
|
Academic Article
|
Superior mesenteric vein thrombosis after colectomy in a patient with Crohn's disease.
|
Academic Article
|
Colonic infiltration with chronic myelomonocytic leukemia.
|
Academic Article
|
Agile patency system eliminates risk of capsule retention in patients with known intestinal strictures who undergo capsule endoscopy.
|
Academic Article
|
Positron emission tomography (PET) used to image subclinical inflammation associated with ulcerative colitis (UC) in remission.
|
Academic Article
|
The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient survey.
|
Academic Article
|
Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis.
|
Academic Article
|
Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study.
|
Academic Article
|
Impact of ulcerative colitis from patients' and physicians' perspectives: Results from the UC: NORMAL survey.
|
Academic Article
|
Response to biologic therapy in Crohn's disease is improved with early treatment: an analysis of health claims data.
|
Academic Article
|
Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?
|
Academic Article
|
Effect of adalimumab on clinical laboratory parameters in patients with Crohn's disease: results from the CHARM trial.
|
Academic Article
|
Two brothers with skewed thiopurine metabolism in ulcerative colitis treated successfully with allopurinol and mercaptopurine dose reduction.
|
Academic Article
|
Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study.
|
Academic Article
|
miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes.
|
Academic Article
|
Total abdominal colectomy for refractory ulcerative colitis. Surgical treatment in evolution.
|
Academic Article
|
Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral center.
|
Academic Article
|
Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.
|
Academic Article
|
Dynamic neural networks supporting memory retrieval.
|
Academic Article
|
Serum adalimumab concentration and clinical remission in patients with Crohn's disease.
|
Academic Article
|
Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.
|
Academic Article
|
Summaries for patients. Increased risk for gastrointestinal cancer in childhood cancer survivors.
|
Academic Article
|
Screening for sleep disorders in pediatric primary care: are we there yet?
|
Academic Article
|
Patient perceptions of fecal microbiota transplantation for ulcerative colitis.
|
Academic Article
|
Mucosal healing is associated with improved long-term outcome of maintenance therapy with natalizumab in Crohn's disease.
|
Academic Article
|
Incidence and predictors of clinical response, re-induction dose, and maintenance dose escalation with certolizumab pegol in Crohn's disease.
|
Academic Article
|
Optimal doses of methotrexate combined with anti-TNF therapy to maintain clinical remission in inflammatory bowel disease.
|
Academic Article
|
Clinical presentation and disease course of inflammatory bowel disease differs by race in a large tertiary care hospital.
|
Academic Article
|
Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis.
|
Academic Article
|
Penetrating Disease, Narcotic Use, and Loop Ostomy Are Associated with Ostomy and IBD-related Complications After Ostomy Surgery in Crohn's Disease Patients.
|
Academic Article
|
Deep enteroscopy with a conventional colonoscope: initial multicenter study by using a through-the-scope balloon catheter system.
|
Academic Article
|
Health Insurance Paid Costs and Drivers of Costs for Patients With Crohn's Disease in the United States.
|
Academic Article
|
Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia.
|
Academic Article
|
Patients with Ulcerative Colitis Are More Concerned About Complications of Their Disease than Side Effects of Medications.
|
Academic Article
|
Clostridium Difficile Infection in Ulcerative Colitis: Can Alteration of the Gut-associated Microbiome Contribute to Pouch Failure?
|
Academic Article
|
Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's Disease.
|
Academic Article
|
Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study.
|
Academic Article
|
Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial.
|
Academic Article
|
Many Inflammatory Bowel Disease Patients Are Not Immune to Measles or Pertussis.
|
Academic Article
|
Primary Rosai-Dorfman disease of the femur.
|
Academic Article
|
The Crohn's and Colitis Foundation of America Survey of Inflammatory Bowel Disease Patient Health Care Access.
|
Academic Article
|
Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
|
Academic Article
|
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.
|
Academic Article
|
Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States.
|
Academic Article
|
Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease.
|
Academic Article
|
Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon.
|
Academic Article
|
Tracking microbial colonization in fecal microbiota transplantation experiments via genome-resolved metagenomics.
|
Academic Article
|
Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease.
|
Academic Article
|
Utility of video capsule endoscopy for longitudinal monitoring of Crohn's disease activity in the small bowel: a prospective study.
|
Academic Article
|
The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease.
|
Academic Article
|
Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.
|
Academic Article
|
Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease.
|
Academic Article
|
Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel Diseases.
|
Academic Article
|
Efficacy of Vedolizumab in Fistulising Crohn's Disease: Exploratory Analyses of Data from GEMINI 2.
|
Academic Article
|
Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing--ASCEND I and II combined analysis.
|
Academic Article
|
Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares.
|
Academic Article
|
Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease.
|
Academic Article
|
Low-Dose Metronidazole is Associated With a Decreased Rate of Endoscopic Recurrence of Crohn's Disease After Ileal Resection: A Retrospective Cohort Study.
|
Academic Article
|
Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe.
|
Academic Article
|
Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission.
|
Academic Article
|
Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence.
|
Academic Article
|
Poor Sleep Quality in Crohn's Disease Is Associated With Disease Activity and Risk for Hospitalization or Surgery.
|
Academic Article
|
Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitis.
|
Academic Article
|
Policy and Practice Innovations to Improve Prescribing of Psychoactive Medications for Children.
|
Academic Article
|
A rare case of granulocytic sarcoma in the mandible of a 4-year-old child: a case report and review of the literature.
|
Academic Article
|
Long-term safety of vedolizumab for inflammatory bowel disease.
|
Academic Article
|
Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry.
|
Academic Article
|
The Montefiore community children's project: a controlled study of cognitive and emotional problems of homeless mothers and children.
|
Academic Article
|
Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission.
|
Academic Article
|
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
|
Academic Article
|
Quantitative Variable Assessment of Patellar Instability: An MRI-Based Study.
|
Academic Article
|
Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBD.
|
Academic Article
|
Fecal Microbiota Transplantation for Recurrent C difficile Infection During the COVID-19 Pandemic: Experience and Recommendations.
|
Academic Article
|
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials.
|
Academic Article
|
Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD.
|
Academic Article
|
Long-Term Safety Outcomes of Fecal Microbiota Transplantation: Real-World Data Over 8 Years From the Hong Kong FMT Registry.
|